Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Dec 1;182(6):1807–1814. doi: 10.1084/jem.182.6.1807

Complement-mediated regulation of tissue factor activity in endothelium

PMCID: PMC2192255  PMID: 7500026

Abstract

Inflammation and immunity may be associated with endothelial cell (EC) injury and thrombus formation. We explored the mechanisms through which a humoral immune response directed against the endothelium might promote coagulation. Using the interaction of anti-EC antibodies and complement (C) with cultured EC as a model, we studied the expression and function of tissue factor, a cofactor for factor VIIa-mediated conversion of factor X to Xa. Exposure of EC to anti-EC antibodies and C in sublytic amounts stimulated the synthesis of tissue factor over a period of 16-42 h. Cell surface expression of tissue factor activity required activation of C and assembly of the membrane attack complex, because expression was inhibited by soluble CR1 and was not detected in the absence of C8. Elaboration of tissue factor messenger RNA was observed over a period of 8-30 h and required protein synthesis. Expression of tissue factor was not a direct consequence of the action of C on the EC but was a secondary response that required as an intermediate step the release of interleukin 1 alpha, an early product of the EC response to C activation. These findings suggest that, after the assembly of membrane attack complex on EC, the production of tissue factor and initiation of coagulation in a blood vessel depend on the production of interleukin 1 alpha and on its availability to stimulate affected EC.

Full Text

The Full Text of this article is available as a PDF (985.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bevilacqua M. P., Pober J. S., Majeau G. R., Cotran R. S., Gimbrone M. A., Jr Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984 Aug 1;160(2):618–623. doi: 10.1084/jem.160.2.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brand K., Fowler B. J., Edgington T. S., Mackman N. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol. 1991 Sep;11(9):4732–4738. doi: 10.1128/mcb.11.9.4732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brett J., Gerlach H., Nawroth P., Steinberg S., Godman G., Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med. 1989 Jun 1;169(6):1977–1991. doi: 10.1084/jem.169.6.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. COCHRANE C. G., WEIGLE W. O., DIXON F. J. The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis. J Exp Med. 1959 Sep 1;110:481–494. doi: 10.1084/jem.110.3.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Campbell W. N., Ding X., Goldblum S. E. Interleukin-1 alpha and -beta augment pulmonary artery transendothelial albumin flux in vitro. Am J Physiol. 1992 Jul;263(1 Pt 1):L128–L136. doi: 10.1152/ajplung.1992.263.1.L128. [DOI] [PubMed] [Google Scholar]
  6. Car B. D., Slauson D. O., Doré M., Suyemoto M. M. Endotoxin-mediated bovine alveolar macrophage procoagulant induction is dependent on protein kinase C activation. Inflammation. 1990 Dec;14(6):681–689. doi: 10.1007/BF00916371. [DOI] [PubMed] [Google Scholar]
  7. Carney D. F., Lang T. J., Shin M. L. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J Immunol. 1990 Jul 15;145(2):623–629. [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Cines D. B., Lyss A. P., Reeber M., Bina M., DeHoratius R. J. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest. 1984 Mar;73(3):611–625. doi: 10.1172/JCI111251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Colucci M., Balconi G., Lorenzet R., Pietra A., Locati D., Donati M. B., Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest. 1983 Jun;71(6):1893–1896. doi: 10.1172/JCI110945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dinarello C. A. Interleukin-1. Adv Pharmacol. 1994;25:21–51. doi: 10.1016/s1054-3589(08)60429-9. [DOI] [PubMed] [Google Scholar]
  12. Esmon N. L., Owen W. G., Esmon C. T. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem. 1982 Jan 25;257(2):859–864. [PubMed] [Google Scholar]
  13. Fei H., Berliner J. A., Parhami F., Drake T. A. Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb. 1993 Nov;13(11):1711–1717. doi: 10.1161/01.atv.13.11.1711. [DOI] [PubMed] [Google Scholar]
  14. GERMUTH F. G., Jr A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type. J Exp Med. 1953 Feb 1;97(2):257–282. doi: 10.1084/jem.97.2.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Iida K., Nussenzweig V. Complement receptor is an inhibitor of the complement cascade. J Exp Med. 1981 May 1;153(5):1138–1150. doi: 10.1084/jem.153.5.1138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kolesnick R., Golde D. W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 1994 May 6;77(3):325–328. doi: 10.1016/0092-8674(94)90147-3. [DOI] [PubMed] [Google Scholar]
  18. Lau C. S., McLaren M., Hanslip J., Kerr M., Belch J. J. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis. Ann Rheum Dis. 1993 Sep;52(9):643–649. doi: 10.1136/ard.52.9.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lee W. Y., Butler A. P., Locniskar M. F., Fischer S. M. Signal transduction pathway(s) involved in phorbol ester and autocrine induction of interleukin-1 alpha mRNA in murine keratinocytes. J Biol Chem. 1994 Jul 8;269(27):17971–17980. [PubMed] [Google Scholar]
  20. Levin J., Bang F. B. Clottable protein in Limulus; its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh. 1968 Mar 31;19(1):186–197. [PubMed] [Google Scholar]
  21. Mackman N., Fowler B. J., Edgington T. S., Morrissey J. H. Functional analysis of the human tissue factor promoter and induction by serum. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2254–2258. doi: 10.1073/pnas.87.6.2254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Marcum J. A., Atha D. H., Fritze L. M., Nawroth P., Stern D., Rosenberg R. D. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J Biol Chem. 1986 Jun 5;261(16):7507–7517. [PubMed] [Google Scholar]
  23. Moore K. L., Andreoli S. P., Esmon N. L., Esmon C. T., Bang N. U. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest. 1987 Jan;79(1):124–130. doi: 10.1172/JCI112772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nachman R. L., Hajjar K. A., Silverstein R. L., Dinarello C. A. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med. 1986 Jun 1;163(6):1595–1600. doi: 10.1084/jem.163.6.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nawroth P. P., Handley D. A., Esmon C. T., Stern D. M. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A. 1986 May;83(10):3460–3464. doi: 10.1073/pnas.83.10.3460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nawroth P. P., Stern D. M., Kisiel W., Bach R. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. Thromb Res. 1985 Dec 1;40(5):677–691. doi: 10.1016/0049-3848(85)90305-6. [DOI] [PubMed] [Google Scholar]
  27. Nicholson-Weller A., Halperin J. A. Membrane signaling by complement C5b-9, the membrane attack complex. Immunol Res. 1993;12(3):244–257. doi: 10.1007/BF02918256. [DOI] [PubMed] [Google Scholar]
  28. Niculescu F., Rus H., Shin S., Lang T., Shin M. L. Generation of diacylglycerol and ceramide during homologous complement activation. J Immunol. 1993 Jan 1;150(1):214–224. [PubMed] [Google Scholar]
  29. Parker W., Bruno D., Holzknecht Z. E., Platt J. L. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol. 1994 Oct 15;153(8):3791–3803. [PubMed] [Google Scholar]
  30. Platt J. L., Holzknecht Z. E. Porcine platelet antigens recognized by human xenoreactive natural antibodies. Transplantation. 1994 Feb;57(3):327–335. doi: 10.1097/00007890-199402150-00003. [DOI] [PubMed] [Google Scholar]
  31. Platt J. L., Lindman B. J., Geller R. L., Noreen H. J., Swanson J. L., Dalmasso A. P., Bach F. H. The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation. 1991 Dec;52(6):1037–1043. doi: 10.1097/00007890-199112000-00019. [DOI] [PubMed] [Google Scholar]
  32. Platt J. L., Turman M. A., Noreen H. J., Fischel R. J., Bolman R. M., 3rd, Bach F. H. An ELISA assay for xenoreactive natural antibodies. Transplantation. 1990 May;49(5):1000–1001. doi: 10.1097/00007890-199005000-00033. [DOI] [PubMed] [Google Scholar]
  33. Platt J. L., Vercellotti G. M., Lindman B. J., Oegema T. R., Jr, Bach F. H., Dalmasso A. P. Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med. 1990 Apr 1;171(4):1363–1368. doi: 10.1084/jem.171.4.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ponte P., Ng S. Y., Engel J., Gunning P., Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 1984 Feb 10;12(3):1687–1696. doi: 10.1093/nar/12.3.1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ranganathan G., Blatti S. P., Subramaniam M., Fass D. N., Maihle N. J., Getz M. J. Cloning of murine tissue factor and regulation of gene expression by transforming growth factor type beta 1. J Biol Chem. 1991 Jan 5;266(1):496–501. [PubMed] [Google Scholar]
  36. Rapaport S. I. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Thromb Haemost. 1991 Jul 12;66(1):6–15. [PubMed] [Google Scholar]
  37. Roberts H. R., Lozier J. N. New perspectives on the coagulation cascade. Hosp Pract (Off Ed) 1992 Jan 15;27(1):97-105, 109-12. doi: 10.1080/21548331.1992.11705345. [DOI] [PubMed] [Google Scholar]
  38. Ryan J., Brett J., Tijburg P., Bach R. R., Kisiel W., Stern D. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood. 1992 Aug 15;80(4):966–974. [PubMed] [Google Scholar]
  39. Saadi S., Platt J. L. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med. 1995 Jan 1;181(1):21–31. doi: 10.1084/jem.181.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Seeger W., Hartmann R., Neuhoff H., Bhakdi S. Local complement activation, thromboxane-mediated vasoconstriction, and vascular leakage in isolated lungs. Role of the terminal complement sequence. Am Rev Respir Dis. 1989 Jan;139(1):88–99. doi: 10.1164/ajrccm/139.1.88. [DOI] [PubMed] [Google Scholar]
  41. Spicer E. K., Horton R., Bloem L., Bach R., Williams K. R., Guha A., Kraus J., Lin T. C., Nemerson Y., Konigsberg W. H. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5148–5152. doi: 10.1073/pnas.84.15.5148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Stern D. M., Bank I., Nawroth P. P., Cassimeris J., Kisiel W., Fenton J. W., 2nd, Dinarello C., Chess L., Jaffe E. A. Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med. 1985 Oct 1;162(4):1223–1235. doi: 10.1084/jem.162.4.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Tijburg P. N., Ryan J., Stern D. M., Wollitzky B., Rimon S., Rimon A., Handley D., Nawroth P., Sixma J. J., de Groot P. G. Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa. J Biol Chem. 1991 Jun 25;266(18):12067–12074. [PubMed] [Google Scholar]
  44. Wakita K., Marumoto Y., Horiuchi T. Up-regulation of tissue factor mRNA in human umbilical vein endothelial cells by calmodulin inhibitor W7. Thromb Res. 1994 Feb 15;73(3-4):177–184. doi: 10.1016/0049-3848(94)90096-5. [DOI] [PubMed] [Google Scholar]
  45. Wakita K., Stearns-Kurosawa D. J., Marumoto Y. The effect of calcium ionophore A23187 on tissue factor activity and mRNA in endothelial cells. Thromb Res. 1994 Apr 15;74(2):95–103. doi: 10.1016/0049-3848(94)90002-7. [DOI] [PubMed] [Google Scholar]
  46. Wilcox J. N., Smith K. M., Schwartz S. M., Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2839–2843. doi: 10.1073/pnas.86.8.2839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yeh C. G., Marsh H. C., Jr, Carson G. R., Berman L., Concino M. F., Scesney S. M., Kuestner R. E., Skibbens R., Donahue K. A., Ip S. H. Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats. J Immunol. 1991 Jan 1;146(1):250–256. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES